BG103649A - Метод за получаване на епросартан - Google Patents

Метод за получаване на епросартан

Info

Publication number
BG103649A
BG103649A BG103649A BG10364999A BG103649A BG 103649 A BG103649 A BG 103649A BG 103649 A BG103649 A BG 103649A BG 10364999 A BG10364999 A BG 10364999A BG 103649 A BG103649 A BG 103649A
Authority
BG
Bulgaria
Prior art keywords
eprosartan
preparation
relates
Prior art date
Application number
BG103649A
Other languages
English (en)
Other versions
BG63970B1 (bg
Inventor
Richard MATSUOKA
Peng Liu
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG103649A publication Critical patent/BG103649A/bg
Publication of BG63970B1 publication Critical patent/BG63970B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретението се отнася до метод за получаване наепросартан.
BG103649A 1997-02-14 1999-08-10 Метод за получаване на епросартан BG63970B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3819697P 1997-02-14 1997-02-14
PCT/US1998/002411 WO1998035962A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (2)

Publication Number Publication Date
BG103649A true BG103649A (bg) 2000-06-30
BG63970B1 BG63970B1 (bg) 2003-08-29

Family

ID=21898590

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103649A BG63970B1 (bg) 1997-02-14 1999-08-10 Метод за получаване на епросартан

Country Status (41)

Country Link
US (2) US6294675B1 (bg)
EP (1) EP0973769B1 (bg)
JP (1) JP4227671B2 (bg)
KR (1) KR100551667B1 (bg)
CN (1) CN1093128C (bg)
AP (1) AP1202A (bg)
AR (1) AR011126A1 (bg)
AT (1) ATE274511T1 (bg)
AU (1) AU730162B2 (bg)
BG (1) BG63970B1 (bg)
BR (1) BRPI9808642B8 (bg)
CA (1) CA2281471C (bg)
CO (1) CO4950549A1 (bg)
CY (1) CY2551B1 (bg)
CZ (1) CZ296543B6 (bg)
DE (1) DE69825880T2 (bg)
DK (1) DK0973769T3 (bg)
DZ (1) DZ2418A1 (bg)
EA (1) EA001761B1 (bg)
EG (1) EG23780A (bg)
ES (1) ES2224358T3 (bg)
HK (1) HK1026206A1 (bg)
HU (1) HU228098B1 (bg)
ID (1) ID23155A (bg)
IL (4) IL143785A (bg)
IN (1) IN188000B (bg)
MA (1) MA24472A1 (bg)
MY (1) MY120024A (bg)
NO (1) NO317761B1 (bg)
NZ (1) NZ337182A (bg)
OA (1) OA11086A (bg)
PE (1) PE59799A1 (bg)
PL (1) PL192837B1 (bg)
PT (1) PT973769E (bg)
SA (1) SA98190146B1 (bg)
SI (1) SI0973769T1 (bg)
SK (1) SK285125B6 (bg)
TR (1) TR199901935T2 (bg)
UA (1) UA57060C2 (bg)
WO (1) WO1998035962A1 (bg)
ZA (1) ZA981208B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
HUP0103000A3 (en) * 1998-07-20 2002-08-28 Smithkline Beecham Corp Bioenhanced formulations comprising eprosartan in oral solid dosage form and process for their preparation
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
US20100137613A1 (en) * 2006-12-27 2010-06-03 Hetero Drugs Limited Process for eprosartan
CN101896457A (zh) * 2007-10-22 2010-11-24 幽兰研究实验室有限公司 组蛋白脱乙酰基酶抑制剂
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955294B1 (en) 1989-06-14 2003-09-24 Smithkline Beecham Corporation Imidazolyl-alkenoic acid
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
EP0563238B1 (en) 1990-12-14 2002-05-22 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.

Also Published As

Publication number Publication date
DE69825880T2 (de) 2005-09-08
CN1247538A (zh) 2000-03-15
OA11086A (en) 2003-03-13
EA199900741A1 (ru) 2000-02-28
CY2551B1 (en) 2008-07-02
CA2281471C (en) 2007-04-24
NZ337182A (en) 2001-04-27
BR9808642A (pt) 2000-05-23
JP2001511808A (ja) 2001-08-14
KR100551667B1 (ko) 2006-02-13
CO4950549A1 (es) 2000-09-01
PL192837B1 (pl) 2006-12-29
PE59799A1 (es) 1999-08-06
ES2224358T3 (es) 2005-03-01
DK0973769T3 (da) 2004-12-13
HU228098B1 (en) 2012-10-29
EP0973769A1 (en) 2000-01-26
IL143783A (en) 2005-05-17
IL143783A0 (en) 2002-04-21
KR20000071008A (ko) 2000-11-25
DZ2418A1 (fr) 2003-06-26
NO993912D0 (no) 1999-08-13
HUP0001813A3 (en) 2001-07-30
EP0973769A4 (en) 2001-01-24
WO1998035962A1 (en) 1998-08-20
SA98190146B1 (ar) 2006-08-20
IL143784A0 (en) 2002-04-21
IL143785A (en) 2004-12-15
AU6273298A (en) 1998-09-08
SK285125B6 (sk) 2006-06-01
MY120024A (en) 2005-08-30
PT973769E (pt) 2004-11-30
CN1093128C (zh) 2002-10-23
IL131310A0 (en) 2001-01-28
AP9901619A0 (en) 1999-09-30
EP0973769B1 (en) 2004-08-25
TR199901935T2 (xx) 1999-12-21
US20020028951A1 (en) 2002-03-07
BG63970B1 (bg) 2003-08-29
US6458963B1 (en) 2002-10-01
CZ285199A3 (cs) 2000-02-16
CA2281471A1 (en) 1998-08-20
CZ296543B6 (cs) 2006-04-12
AP1202A (en) 2003-09-02
MA24472A1 (fr) 1998-10-01
IL143785A0 (en) 2002-04-21
EA001761B1 (ru) 2001-08-27
AU730162B2 (en) 2001-03-01
JP4227671B2 (ja) 2009-02-18
BRPI9808642B8 (pt) 2021-05-25
PL335074A1 (en) 2000-04-10
IL143784A (en) 2005-05-17
HUP0001813A2 (hu) 2001-06-28
EG23780A (en) 2007-08-13
SK108699A3 (en) 2000-05-16
HK1026206A1 (en) 2000-12-08
IN188000B (bg) 2002-08-03
AR011126A1 (es) 2000-08-02
SI0973769T1 (en) 2004-12-31
NO993912L (no) 1999-08-13
ZA981208B (en) 1998-11-12
US6294675B1 (en) 2001-09-25
UA57060C2 (uk) 2003-06-16
IL131310A (en) 2003-02-12
DE69825880D1 (de) 2004-09-30
NO317761B1 (no) 2004-12-13
ID23155A (id) 2000-03-23
ATE274511T1 (de) 2004-09-15
BR9808642B1 (pt) 2013-11-26

Similar Documents

Publication Publication Date Title
HK1028401A1 (en) A process for the reduction of oxiranyl epothilones to olefinic epothilones
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
ZA964624B (en) Process for the preparation of microcapsule compositions.
ZA961867B (en) Underarm compositions.
ZA9710322B (en) Process for the preparation of benzyl-ethers.
BG102788A (bg) Нови методи за получаване на междинни съединения за пестициди
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
BG103649A (bg) Метод за получаване на епросартан
HUP0100640A3 (en) Process for the preparation of 1,4-dihydropyridines
BG103650A (bg) Метод за получаване на епросартан
ZA968249B (en) Underarm compositions.
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
ZA991514B (en) Production of polyamides.
ZA982255B (en) Process for the preparation of arylmalonates.
EP0617040A3 (en) Production of alkyl phosphites.
ZA968252B (en) Underarm compositions.
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
ZA988397B (en) Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones
BG102563A (bg) Метод и междинни съединения за получаването на пестицидни флуороолефинови съединения
IL118731A0 (en) Process for the preparation of 2,2-dialkyl-arylidene-cycloalkanones
GB9515598D0 (en) Perfumed compositions
KR100641508B1 (en) Improved process for the preparation of phosphites
ZA9710340B (en) Method for the synthesis of deoxypyridinoline.
HK1029577A1 (en) Method for production of 2,4,5-trifluorobenzonitrile 2, 4, 5-
ZA966542B (en) Process for the preparation of 3,3,5-trichloroglutarimide.